What's in Advagene Biopharma Co. Ltd.'s pipeline?

Advagene Biopharma Co. Ltd. has 5 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 2 in Phase 2, 2 in Phase 1.

Which companies overlap with Advagene Biopharma Co. Ltd.'s portfolio?

Top competitors by shared drug class: Akron Molecules AG, Allgenesis Biotherapeutics Inc., Arcus Biosciences, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/advagene-biopharma-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Advagene Biopharma Co. Ltd. — Portfolio Competitive Intelligence Brief

Advagene Biopharma Co. Ltd. pipeline: 1 marketed, 0 filed, 0 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 2 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Inactivated trivalent influenza vaccine	Inactivated trivalent influenza vaccine	marketed

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Akron Molecules AG · 1 shared drug class
Allgenesis Biotherapeutics Inc. · 1 shared drug class
Arcus Biosciences, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Advagene Biopharma Co. Ltd.:

Cite this brief

Drug Landscape (2026). Advagene Biopharma Co. Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/advagene-biopharma-co-ltd. Accessed 2026-05-16.